Effect of the combined use of tramadol and milnacipran on pain threshold in an animal model of fibromyalgia

Korean Journal of Internal Medicine

Volumn 24, Issue 2, 2009, Pages 139-142

  Kim, Seong Ho ^a   Song, Junhwa ^a   Mun, Hyunil ^a   Keon, Uk Park ^a  

^a Dongguk University College of Medicine   (South Korea)

Author keywords

Acidic saline animal model; Fibromyalgia; Milnacipran; Pain; Tramadol

Indexed keywords

ISOFLURANE; MILNACIPRAN; SODIUM CHLORIDE; TRAMADOL; ANTIDEPRESSANT AGENT; CYCLOPROPANE DERIVATIVE; NARCOTIC ANALGESIC AGENT;

ANALGESIA; ANALYTICAL EQUIPMENT; ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; DYNAMIC PLANTAR AESTHESIOMETER; EXPERIMENTAL ANIMAL; EXPERIMENTAL MODEL; FIBROMYALGIA; GASTROCNEMIUS MUSCLE; HINDLIMB; HYPERALGESIA; INJECTION; MALE; NONHUMAN; PAIN; PAIN THRESHOLD; PAW EDEMA; PH; PRESSURE; RAT; TOUCH; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; ANIMAL; ANIMAL BEHAVIOR; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG COMBINATION; DRUG EFFECT; DRUG POTENTIATION; INTRAPERITONEAL DRUG ADMINISTRATION; PAIN ASSESSMENT; SPRAGUE DAWLEY RAT; TIME;

ANALGESICS, OPIOID; ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; CYCLOPROPANES; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FIBROMYALGIA; HYDROGEN-ION CONCENTRATION; HYPERALGESIA; INJECTIONS, INTRAPERITONEAL; MALE; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; RATS; RATS, SPRAGUE-DAWLEY; SODIUM CHLORIDE; TIME FACTORS; TRAMADOL;

EID: 67650732507     PISSN: 12263303     EISSN: None     Source Type: Journal    
DOI: 10.3904/kjim.2009.24.2.139     Document Type: Article

References (20)

1. Sluka KA, Kalra A, Moore SA. Unilateral intramuscular injections of acidic saline produce a bilateral, long-lasting hyperalgesia. Muscle Nerve 2001;24:37-46. (Pubitemid 32038025)
2. Harte SE, Kim SH, Clauw DJ, Morrow TJ. Altered regional cerebral blood flow at rest in an animal model of fibromyalgia [Abstract]. Arthritis Rheum 2007;56:S9.
3. Kwiatek R, Barnden L, Tedman R, et al. Regional cerebral blood flow in fibromyalgia: single-photon-emission computed tomography evidence of reduction in the pontine tegmentum and thalami. Arthritis Rheum 2000;43:2823-2833. (Pubitemid 32001750)
4. Mountz JM, Bradley LA, Modell JG, et al. Fibromyalgia in women: abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis Rheum 1995;38:926-938.
5. Arnold LM. Biology and therapy of fibromyalgia: new therapies in fibromyalgia. Arthritis Res Ther 2006;8:212.
6. Gendreau RM, Thorn MD, Gendreau JF, et al. Efficacy of milnacipran in patients with fibromyalgia. J Rheumatol 2005;32:1975-1985.
7. Harris RE, Clauw DJ, Scott DJ, McLean SA, Gracely RH, Zubieta JK. Decreased central mu-opioid receptor availability in fibromyalgia. J Neurosci 2007;27:10000-10006.
8. Gatch MB, Negus SS, Mello NK. Antinociceptive effects of monoamine reuptake inhibitors administered alone or in combination with mu opioid agonists in rhesus monkeys. Psychopharmacology 1998;135:99-106. (Pubitemid 28055455)
9. Sierralta F, Pinardi G, Mendez M, Miranda HF. Interaction of opioids with antidepessant-induced antinociception. Psychopharmacology 1995;122:374-378.
10. Bennett RM, Kamin M, Karim R, Rosenthal N. Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebocontrolled study. Am J Med 2003;114:537-545. (Pubitemid 36577256)
11. Isenberg KE, Cicero TJ. Possible involvement of opiate receptors in the pharmacological profiles of antidepressant compounds. Eur J Pharmacol 1984;103:57-63.
12. Marchand F, Ardid D, Chapuy E, Alloui A, Jourdan D, Eschalier A. Evidence for an involvement of supraspinal δ-and spinal μ-opioid receptors in the antihyperalgesic effect of chronically administered clomipramine in mononeuropathic rats. J Pharmacol Exp Ther 2003;307:268-274. (Pubitemid 37151917)
13. Gray AM, Spencer PS, Sewell RD. The involvement of the opioidergic system in the antinociceptive mechanism of action of antidepressant compounds. Br J Pharmacol 1998;124:669-674. (Pubitemid 28276803)
14. Dziedzicka-Wasylewska M, Rogoz Z. The effect of prolonged treatment with imipramine and electroconvulsive shock on the levels of endogenous enkephalins in the nucleus accumbens and the ventral tegmentum of the rat. J Neural Transm Gen Sect 1995;102:221-228. (Pubitemid 26010729)
15. Sacerdote P, Brini A, Mantegazza P, Panerai AE. A role for serotonin and beta-endorphin in the analgesia induced by some tricyclic antidepressant drugs. Pharmacol Biochem Behav 1987;26:153-158. (Pubitemid 18005618)
16. Borsook D, Burstein R, Becerra L. Functional imaging of the human trigeminal system: opportunities for new insights into pain processing in health and disease. J Neurobiol 2004;61:107-125. (Pubitemid 39287773)
17. Rustioni A. Modulation of sensory input to the spinal cord by presynaptic ionotropic glutamate receptors. Arch Ital Biol 2005;143:103-112.
18. Kim SH, Lee J. Altered pain-associated molecules in the brain of an animal model of fibromyalgia-preliminary data [Abstract]. Ann Rheum Dis 2008;67:254.
19. Crofford LJ, Rowbotham MC, Mease PJ, et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2005;52:1264-1273. (Pubitemid 40530135)
20. Yokoyama T, Maeda Y, Audette KM, Sluka KA. Pregabalin reduces muscle and cutaneous hyperalgesia in two models of chronic muscle pain in rats. J Pain 2007;8:422-429. (Pubitemid 46678933)